IRIS - Res&Arch Institutional Research Information System - Research & Archive

BECATTINI, Cecilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.630
AS - Asia 5.604
EU - Europa 4.400
SA - Sud America 1.130
AF - Africa 149
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 17.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.458
SG - Singapore 2.690
BR - Brasile 866
IT - Italia 848
IE - Irlanda 816
RU - Federazione Russa 757
CN - Cina 747
HK - Hong Kong 690
VN - Vietnam 605
UA - Ucraina 358
DE - Germania 335
FR - Francia 330
SE - Svezia 275
FI - Finlandia 219
GB - Regno Unito 155
BD - Bangladesh 144
IN - India 138
KR - Corea 132
TR - Turchia 89
AR - Argentina 83
CA - Canada 71
MX - Messico 66
IQ - Iraq 65
AT - Austria 55
PL - Polonia 47
PK - Pakistan 45
EC - Ecuador 40
NL - Olanda 39
ES - Italia 38
ZA - Sudafrica 37
UZ - Uzbekistan 34
JP - Giappone 33
VE - Venezuela 32
CO - Colombia 31
CH - Svizzera 28
CL - Cile 27
SA - Arabia Saudita 24
ID - Indonesia 22
JO - Giordania 21
TN - Tunisia 21
EG - Egitto 19
LB - Libano 17
MA - Marocco 17
PH - Filippine 17
KE - Kenya 16
LT - Lituania 16
PE - Perù 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
BE - Belgio 13
MY - Malesia 11
BO - Bolivia 10
CZ - Repubblica Ceca 10
UY - Uruguay 10
GR - Grecia 9
MK - Macedonia 9
PS - Palestinian Territory 9
DZ - Algeria 8
JM - Giamaica 8
OM - Oman 8
RO - Romania 8
BG - Bulgaria 7
CR - Costa Rica 7
NP - Nepal 7
AZ - Azerbaigian 6
ET - Etiopia 6
IL - Israele 6
KG - Kirghizistan 6
AL - Albania 4
AO - Angola 4
CI - Costa d'Avorio 4
DK - Danimarca 4
EU - Europa 4
GT - Guatemala 4
KH - Cambogia 4
KW - Kuwait 4
PT - Portogallo 4
KZ - Kazakistan 3
RS - Serbia 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BW - Botswana 2
BY - Bielorussia 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GY - Guiana 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
LY - Libia 2
MD - Moldavia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
Totale 17.898
Salva come PNG Salva come JPEG
Città #
Singapore 1.932
Chandler 887
Dublin 812
Hong Kong 688
San Jose 657
Ashburn 457
San Mateo 381
Dong Ket 295
Moscow 295
Santa Clara 257
Boardman 254
Altamura 228
Perugia 227
Lauterbourg 214
Medford 204
Princeton 200
Lawrence 194
Jacksonville 179
Beijing 159
Ann Arbor 133
Seoul 132
Wilmington 130
Ho Chi Minh City 128
Los Angeles 124
Munich 113
Des Moines 111
New York 110
Andover 103
The Dalles 81
São Paulo 80
Hanoi 66
Helsinki 63
Piscataway 61
Redmond 55
San Paolo di Civitate 53
Nuremberg 48
Dallas 43
Orem 43
Frankfurt am Main 42
Saint Petersburg 42
Izmir 40
Turku 38
Norwalk 37
Chicago 36
Brooklyn 31
Shanghai 31
Warsaw 31
Baghdad 28
Montreal 28
Rome 28
Rio de Janeiro 27
Stockholm 27
Tokyo 26
Columbus 25
Hefei 25
Denver 24
Falls Church 24
Chennai 23
London 21
Houston 20
Johannesburg 20
Lahore 20
Amelia 19
Atlanta 19
Boston 19
Tashkent 19
Manchester 18
Amman 17
Phoenix 17
Redwood City 17
Toronto 17
Amsterdam 16
San Francisco 16
Seattle 16
Brasília 15
Nairobi 15
Vienna 15
Da Nang 14
Mexico City 14
Mumbai 14
Quito 14
Belo Horizonte 13
Bologna 13
Dhaka 13
New Delhi 13
Ribeirão Preto 13
Woodbridge 13
Brussels 12
Guarulhos 12
Milan 12
Poplar 12
Ankara 11
Curitiba 11
Haiphong 11
Jeddah 11
Lappeenranta 11
Salvador 11
Buffalo 10
Caracas 10
Falkenstein 10
Totale 11.424
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 160
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 148
Bedside sonography assessment of extravascular lung water increase after major pulmonary resection in non-small cell lung cancer patients 148
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 142
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 142
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 135
Aspirin for preventing the recurrence of venous thromboembolism. 130
Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study 125
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study 121
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 118
Search for SARS-CoV-2 RNA in platelets from COVID-19 patients 117
Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Effect of Anticoagulation and Its Timing: The RAF Study 115
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack. 113
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 111
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study 111
A prospective study on cardiovascular events after acute pulmonary embolism 110
Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation) 110
Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study 108
Acute pulmonary embolism: external validation of an integrated risk stratification model. 107
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 107
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 106
Definition of major bleeding: Prognostic classification 106
Anticoagulation in patients with isolated distal deep vein thrombosis: a meta-analysis 105
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 105
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 105
A new strategy for anticoagulation: The factor XI inhibitors 104
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 103
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 103
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 103
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 102
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC) 102
Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. 102
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events 101
Initial treatment of venous thromboembolism 101
Acute cardiovascular events in patients with community acquired pneumonia: results from the observational prospective FADOI-ICECAP study 101
Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcme-based meta-analysis 100
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 100
Risk factors for adverse short-term outcome in patients with pulmonary embolism 99
Acute pulmonary embolism. 99
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 99
D-dimer for riskstratification in patients with acute pulmonary embolism. 98
Acute pulmonary embolism: risk stratification in the emergency department. 98
Risk of recurrent venous thromboembolism after acute pulmonary embolism: Role of residual pulmonary obstruction and persistent right ventricular dysfunction. A meta-analysis 98
[Determinants of prognosis in acute pulmonary embolism: the role of serum troponins]. 97
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 97
ECOGRAFICA TRANS-TORACICA NELLA VALUTAZIONE DEI FLUIDI POLMONARI EXTRAVASCOLARI DOPO CHIRURGIA TORACICA MAGGIORE 95
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 95
Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation 95
Venous thromboembolism and atherosclerosis: common denominators or different diseases? 94
Mortality in patients with intracerebral hemorrhage associated with antiplatelet agents, oral anticoagulants or no antithrombotic therapy 94
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 93
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 93
Aspirin for the prevention of recurrent venous thromboembolism the INSPIRE collaboration 92
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 92
Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing 92
Rivaroxaban for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Design of the PRO-LAPS II STUDY 92
Apixaban for the treatment of venous thromboembolism associated with cancer 92
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS) 92
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 91
Impact of Thrombolytic Therapy on the Long-Term Outcome of Intermediate-Risk Pulmonary Embolism 91
Challenging anticoagulation cases: A case of pulmonary embolism shortly after spontaneous brain bleeding 91
New anticoagulants 90
Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism 90
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 90
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 90
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 89
Thrombolysis in submassive pulmonary embolism 89
Recurrent venous thromboembolism in men and women 88
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 88
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 88
Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis 88
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 87
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 87
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: Systematic review and meta-analysis 87
Acute treatment of venous thromboembolism 87
Direct thrombin inhibitors for the prevention of venous thromboembolism after major orthopaedic surgery 86
Combined oral anticoagulants and antiplatelets: benefits and risks. 86
ANMCO statement: Arterial and venous thromboembolism: What implications for clinical practice? 86
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 86
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 86
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 85
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 85
Lo studio EINSTEIN CHOICE 84
PREvention of VENous Thromboembolism in Hemorrhagic Stroke Patients-PREVENTIHS Study: A Randomized Controlled Trial and a Systematic Review and Meta-Analysis 84
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation. 83
Padua prediction score or clinical judgment for decision making on antithrombotic prophylaxis: a quasi-randomized controlled trial 83
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 82
Cardiovascular risk factors and venous thromboembolism: a meta-analysis. 82
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 81
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 81
Updated meta-analysis on prevention of venous thromboembolism in ambulatory cancer patients 81
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance 80
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism 80
Holter monitoring to detect silent atrial fibrillation in high-risk subjects: the Perugia General Practitioner Study 80
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 80
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 80
Extended oral anticoagulant therapy after a first episode of pulmonary embolism. 79
Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism. 79
Predictors of mortality from pulmonary embolism andtheir influence on clinical management. 79
Totale 9.811
Salva come PNG Salva come JPEG
Categoria #
all - tutte 89.311
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.311
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 0 0 0 0 0 0 305
2021/20221.566 27 259 20 50 81 19 14 457 52 111 220 256
2022/20233.014 221 658 38 206 233 347 0 110 1.063 13 91 34
2023/20241.065 80 110 71 15 12 5 261 32 67 59 212 141
2024/20253.286 24 270 89 152 383 253 139 258 685 214 523 296
2025/20267.304 585 519 428 952 980 554 1.299 383 666 573 260 105
Totale 18.442